Dr Andre lev-Weissberg’s Presentation on Weight Loss at The LDN 2014 Conference

In this presentation Dr Andre lev-Weissberg talks about Low Dose Naltrexone (LDN) as an immunomodulator. As a success story it modulates, it heals and restores the body to the status quo of what it was before the immune dysregulation. 

The objectives of this presentation are:

Low Dose Naltrexone - success story as immunomodulator.

Learning from clinical practice with the use of low-toxicity pharmaceuticals that have a wide range of applications.

Discuss neurobiologic significance of endorphins in homeostasis of weight.

Discuss metabolic syndrome as a proinflammatory state.

Discuss possible application of LDN in management of obesity from above two perspectives.

Provide a practical approach to using LDN using clinical vignettes.

To watch more presentations about Low Dose Naltrexone please visit https://ldnresearchtrust.org/ldn-conferences